Pharmaceutical Innovation and Access to Medicines

Pharmaceutical Innovation and Access to Medicines - OECD

Promoting competition in off-patent markets. Competitive off-patent markets can deliver savings without loss of benefit for patients, by moving ...

Pharmaceutical Innovation and Access to Medicines - OECD iLibrary

This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises ...

pharmaceutical innovation and access to medicines

facing in ensuring appropriate access to innovative medicines to all those in need. • Propose policy options, while stressing for each of them the expected ...

Pharmaceutical Innovation and Access to Medicines - OECD

Despite this, policy makers and other stakeholders have become increasingly concerned about the outputs of the pharmaceutical innovation system. Many new drugs, ...

3 Policies to support innovation and access to medicines - NCBI

Free pricing applies under the ATU, which means that the pharmaceutical company can set the price. Once the medicine has received marketing authorization, a ...

Improving public access to medicines and promoting ...

Improving public access to medicines and promoting pharmaceutical innovation ... Health is a fundamental human right, and achieving equality in ...

Foreword | Pharmaceutical Innovation and Access to Medicines

This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing.

Innovation, Access to Medicines and Health Technologies - PAHO

It supports countries in addressing barriers to access, addressing challenges across the medical product's full life cycle, strengthening regulatory capacity ...

#AlwaysInnovating: The pharmaceutical innovation journey | IFPMA

Turning a scientific idea into a new medicine or vaccine requires significant expertise, time, and investment. The innovative pharmaceutical industry ...

Intellectual property and access to medicine - Oxfam

Stricter patent rules in a few countries may generate greater profits for drug companies, but won't lead to additional innovation that would meet the public ...

Pharmaceutical Innovation and Access to Medicines. OECD Health ...

PDF | On Nov 20, 2018, Valerie Paris and others published Pharmaceutical Innovation and Access to Medicines. OECD Health Policy Studies, (Paris; ...

How to balance valuable innovation with affordable access to ...

Background: Countries are struggling to provide affordable access to medicines while supporting the market entry of innovative, ...

Improving access to medicines and promoting pharmaceutical ...

Among European companies, 79.2% of product innovations and 45.6% of process innovations are patented in pharmaceuticals. (average values being, ...

OECD Health Policy Studies Pharmaceutical Innovation and Access ...

This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises ...

Pharmaceutical Innovation and Access to Essential Medicines

A system of innovation and access to medicines that allows millions of people to die when the drugs that would save their lives can be developed, produced and ...

Privatized Pharmaceutical Innovation vs Access to Essential ...

This Viewpoint proposes a framework for promoting pharmaceutical innovation while ensuring access and affordability of new drugs on a global ...

OECD - Pharmaceutical Innovation and Access to Medicines

OECD - Pharmaceutical Innovation and Access to Medicines · Increasing the value of spending on medicines. · Ensuring access in countries at ...

Ensuring access to medicines: How to stimulate innovation to meet ...

pharmaceutical innovation cannot be underestimated. The bulk of basic research paid with public money, and the share of public R&D spend are especially ...

Social pharmaceutical innovation and alternative forms of research ...

Other innovative initiatives target the cost containment on drugs for rare diseases and to ensure the sustainability of health systems more ...

Trips, Pharmaceutical Innovation and Access to Medicines

A mix of economic and political incentives has influenced their decision, and the Post-Doha TRIPS Agreement has added incentives that may favor ...